← Alle mensen

BB

Beatrice Borelli

6 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 februari 2026

Individual Patient Data Meta-analyse of Consensus Molecular Subtypes as Biomarkers of Eerstelijns Behandeling in RAS ...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026-01

FOLFOXIRI-bev met of zonder atezolizumab bij gemetastaseerd CRC: AtezoTRIBE langetermijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 augustus 2024

mFOLFOXIRI plus panitumumab versus FOLFOX plus panitumumab bij RAS/BRAF-wildtype CRC: VOLFI fase II

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 september 2022

FOLFOXIRI-bevacizumab met of zonder atezolizumab bij gemetastaseerd CRC: AtezoTRIBE fase II

The Lancet. Oncology · 2022-07

Bevacizumab-onderhoud met of zonder metronomisch capecitabine bij CRC: fase II

European journal of cancer (Oxford, England : 1990) · 2019-03